您当前的位置:
首页 >
文章列表页 >
Clinical Randomized Controlled Trial of Traditional Chinese Medicine Compound Shenlong Decoction Granules in Treatment of Idiopathic Pulmonary Fibrosis
更新时间:2025-04-30
    • Clinical Randomized Controlled Trial of Traditional Chinese Medicine Compound Shenlong Decoction Granules in Treatment of Idiopathic Pulmonary Fibrosis

    • In the field of treating idiopathic pulmonary fibrosis, research has shown that the traditional Chinese medicine compound Shenlong decoction can alleviate symptoms, improve quality of life, and has potential advantages in improving lung function.
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 11, Pages: 237-245(2025)
    • DOI:10.13422/j.cnki.syfjx.20251291    

      CLC: R259;R575;R256.4
    • Received:16 November 2024

      Accepted:2025-02-17

      Published Online:25 March 2025

      Published:05 June 2025

    移动端阅览

  • SI Qi,ZANG Ningzi,WANG Mei,et al.Clinical Randomized Controlled Trial of Traditional Chinese Medicine Compound Shenlong Decoction Granules in Treatment of Idiopathic Pulmonary Fibrosis[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(11):237-245. DOI: 10.13422/j.cnki.syfjx.20251291.

  •  
  •  

0

Views

2

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Exploring Immune Mechanism of Alveolar Epithelial Homeostasis in Idiopathic Pulmonary Fibrosis Based on Principle of "Spleen being in Charge of Defensive Function"
Clinical Efficacy of Jinwei Pingchuan Decoction in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Phlegm-heat Obstruction in Lung Syndrome
Clinical Efficacy of Fuyuan Tongluo Prescription in Prevention and Treatment of Restenosis with Collateral Obstruction Syndrome After Interventional Operation of Lower Limb Arteriosclerosis Obliterans
Rho/ROCK:key Mediator of Pulmonary Fibrosis and New Target of TCM for IPF Prevention and Treatment

Related Author

SI Qi
PANG Lijian
LYU Xiaodong
CHEN Jie
PANG Lijian
ZANG Ningzi
WANG Jingyu
LI Siyu

Related Institution

Beijing University of Chinese Medicine Third Affiliated Hospital
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan & Ministry of Education of PR China,Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Academy of Chinese Medical Sciences,Henan University of Chinese Medicine
Beijing Hospital of Traditional Chinese Medicine(TCM) Affiliated to Capital Medical University
ZHANG Binghou Studio of National Famous TCM Inheritance
0